Related Experiment Video
Updated: Jun 2, 2026

MicroRNA Based Liquid Biopsy: The Experience of the Plasma miRNA Signature Classifier (MSC) for Lung Cancer Screening
Published on: October 26, 2017
MicroRNA in lung cancer diagnostics and treatment
Marcin Skrzypski1, Rafał Dziadziuszko, Jacek Jassem
1Department of Oncology and Radiotherapy, Medical University of Gdansk, Gdańsk, Poland. mskrzypski@gumed.edu.pl
Abstract:
MicroRNAs (miRs) are short RNA chains that regulate gene expression by inhibition of mRNA translation. Their expression is often deranged in cancer. Increasing evidence indicates that these molecules play an important role in oncogenesis and cancer progression. This review focuses on the clinical application of miRs in lung cancer, with the emphasis on detection of early lung cancer, prognostication and chemotherapy sensitivity prediction. Methodological aspects of studies on prognostic markers in early NSCLC are outlined in detail. Finally, modulation of miR expression in lung cancer as a therapeutic possibility is discussed.
More Related Videos
Related Concept Videos
MicroRNAs
MicroRNAs
lncRNA - Long Non-coding RNAs

